当前位置:主页 > 医学论文 > 中医论文 >

糖尿病周围神经病变的中医证型及相关因素研究

发布时间:2018-09-01 12:03
【摘要】:目的:分析中医证型分布规律,并调查患者相关临床资料,探讨相关指标与各证型间的相关性,以期总结中医证型分布规律,了解各危险成分于各证型中具体表现,进而对其发展变化做深入分析与探索,期于中医辨证治疗DPN提供理论、临床基础。材料与方法:选取2015年2月至2016年1月我院内分泌科诊治的DPN患者160例为研究对象,据《糖尿病中医防治指南》DPN中医辨证以及相关诊断标准明确诊断。且进行辨证分型,具体包含:肝肾亏虚证、痰瘀阻络证、阴虚血瘀证、气虚血瘀证。记录所有患者的年龄,性别,体重指数,糖尿病病程,糖化血红蛋白,甘油三脂,高、低密度脂蛋白等指标,将之与不同分型做相关性分析。结果:1.所选160例DPN患者中,男性64例,女性96例,分别占比40%、60%。其中肝肾亏虚证52例(32.5%);痰瘀阻络证32例(20%);气虚血瘀证28例(17.5%);阴虚血瘀证48例(30%)。不同证型患者的性别比无明显差异,无统计学意义(P0.05)。2.各组间两两比较,肝肾亏虚证年龄与阴虚血瘀证、气虚血瘀证年龄相比差异显著有统计学意义(P0.05),表明肝肾亏虚证组年龄较阴虚血瘀证、气虚血瘀证大。痰瘀阻络证年龄与气虚血瘀证年龄相比差异显著有统计学意义(P0.05);而肝肾亏虚证、痰瘀阻络证两组间年龄相比无显著性差异(P0.05)。气虚血瘀证与阴虚血瘀证两组间相比无显著性差异,不具有统计学意义。(P0.05)。3.各证型患者的体重指数比较,痰瘀阻络证气虚血瘀证阴虚血瘀证肝肾亏虚证;其中两组间比较提示痰瘀阻络证组与肝肾亏虚证组相比差异显著(P0.01),痰瘀阻络证组与其他各组相比有差异(P0.05),肝肾亏虚证组与气虚血瘀证组相比差异显著(P0.05),肝肾亏虚证组与阴虚血瘀证组相比差异显著(P0.05),而气虚血瘀证组与阴虚血瘀证组相比无显著性差异(P0.05)。4.各证型患者病程比较,肝肾亏虚证痰瘀阻络证阴虚血瘀证气虚血瘀证。各组间两两比较,肝肾亏虚证病程与气虚血瘀证及阴虚血瘀证相比差异显著有统计学意义(P0.05);而肝肾亏虚证与痰瘀阻络证组间病程相比无显著性差异(P0.05);痰瘀阻络证与气虚血瘀证、阴虚血瘀证之间相比有显著差异(P0.05);气虚血瘀证组与阴虚血瘀证组间病程相比无明显差异(P0.05)。5.各证型血糖相关指标如空腹血糖、餐后2小时血糖、糖化血红蛋白比较,结果显示阴虚血瘀证患者的空腹血糖、餐后2小时血糖为所有证型中最高,且与肝肾亏虚证组患者比较差异显著(P0.05);不同证型患者的糖化血红蛋白水平均高于正常值,阴虚血瘀证患者最高,痰瘀阻络证次之,肝肾亏虚最低;其中阴虚血瘀证与肝肾亏虚证组患者比较差异显著(P0.05),其余各组间比较无显著差异(P0.05)。6.各证型血脂相关指标如TC、TG、HDL-C与LDL-C比较,结果显示TC方面,阴虚血瘀证组的TC较高,与气虚血瘀证组和肝肾亏虚证组的比较有显著性差异具有有统计学意义(P0.05),与痰瘀阻络证组比较无显著性差异(P0.05),而气虚血瘀证组、肝肾亏虚证组与痰瘀阻络证组三组之间比较差异不显著(P0.05);LDL-C方面,以阴虚血瘀证组最高,与气虚血瘀证组比较有显著性意义(P0.05),其余各组间比较无显著性差异(P0.05);TG、HDL-C方面,痰瘀阻络证组的TG、HDL-C值均较高,但各组间两两比较差异均不显著(P0.05)。结论:1.糖尿病周围神经病变中医证型分布由多到少依次为肝肾亏虚证,阴虚血瘀证,痰瘀阻络证,气虚血瘀证。2.肝肾亏虚型糖尿病周围神经病变病程较长且年龄偏大。3.痰瘀阻络型患者BMI均值明显高于其他各组。4.不同证型组间均存在不同程度的血糖、血脂异常。
[Abstract]:Objective: To analyze the distribution of TCM syndromes, investigate the clinical data of patients, and explore the correlation between the relevant indicators and syndromes, so as to summarize the distribution of TCM syndromes, to understand the specific manifestations of various dangerous components in each syndromes, and to make in-depth analysis and exploration of its development and change, so as to provide theory and clinical evidence for the treatment of DPN by TCM syndrome differentiation. Materials and Methods: 160 cases of DPN diagnosed and treated in the Department of Endocrinology of our hospital from February 2015 to January 2016 were selected as the research object, and the diagnosis was made according to the syndrome differentiation of traditional Chinese medicine and relevant diagnostic criteria. The age, sex, body mass index, course of diabetes, glycosylated hemoglobin, triglyceride, high, low density lipoprotein and other indicators of all patients were recorded and correlated with different types. Results: 1. Among 160 DPN patients, 64 were males and 96 were females, accounting for 40% and 60% respectively. There was no significant difference in sex ratio among different syndrome types (P 0.05). 2. There was significant difference between the age of liver and kidney deficiency syndrome and yin deficiency and blood stasis syndrome, and the age of qi deficiency and blood stasis syndrome was significantly different (P 0.05). The age of phlegm-stasis obstructing collateral syndrome was significantly different from that of Qi-deficiency and blood-stasis syndrome (P 0.05), but there was no significant difference between the two groups of liver-kidney deficiency and phlegm-stasis obstructing collateral syndrome (P 0.05). 3. Comparing the body mass index of the patients with different syndrome types, the syndrome of phlegm-stasis obstructing collaterals with Qi deficiency and blood stasis with Yin deficiency and blood stasis with liver and kidney deficiency syndrome is of deficiency of liver and kidney; the comparison between the two groups indicates that there is a significant difference between the syndrome of phlegm-stasis obstructing collaterals and the syndrome of liver and kidney deficiency (P 0.01), the syndrome of phlegm-stasis obstructing collaterals is different from the other groups (P 0.05 Significant (P 0.05), liver and kidney deficiency syndrome group and Yin deficiency and blood stasis syndrome group was significantly different (P 0.05), but Qi deficiency and blood stasis syndrome group and Yin deficiency and blood stasis syndrome group was no significant difference (P 0.05). 4. Comparing the course of disease of each syndrome type, liver and kidney deficiency syndrome of phlegm and blood stasis syndrome of Yin deficiency and blood stasis syndrome. Stasis syndrome and yin deficiency and blood stasis syndrome were significantly different (P 0.05); liver and kidney deficiency syndrome and phlegm stagnation collateral syndrome were not significantly different (P 0.05); phlegm stagnation collateral syndrome and Qi deficiency and blood stasis syndrome, Yin deficiency and blood stasis syndrome were significantly different (P 0.05); Qi deficiency and blood stasis syndrome and yin deficiency and blood stasis syndrome were not significantly different (P 0.05); The results showed that the fasting blood glucose of the patients with Yin deficiency and blood stasis syndrome and the blood glucose of 2 hours after meal were the highest among all the syndrome types, and there was significant difference between the patients with liver and kidney deficiency syndrome and the patients with different syndrome types (P 0.05). Compared with the normal value, the patients with Yin deficiency and blood stasis syndrome were the highest, phlegm and blood stasis obstructing collaterals syndrome was the second, liver and kidney deficiency was the lowest; the difference between the patients with Yin deficiency and blood stasis syndrome and the patients with liver and kidney deficiency syndrome was significant (P 0.05), and there was no significant difference between the other groups (P 0.05). 6. TC in group A was higher than that in group B (P 0.05), but there was no significant difference between group B (P 0.05), group B (P 0.05), group B (P 0.05), and group B (P 0.05). Syndrome group was the highest, compared with Qi deficiency and blood stasis syndrome group, there was significant difference (P 0.05), there was no significant difference between the other groups (P 0.05); TG, HDL-C, the phlegm stasis collateral syndrome group TG, HDL-C values were higher, but there was no significant difference between the two groups (P 0.05). Conclusion: 1. Diabetic peripheral neuropathy of traditional Chinese medicine syndrome distribution from more to less in turn is liver. Kidney deficiency syndrome, Yin deficiency and blood stasis syndrome, phlegm and blood stasis syndrome, Qi deficiency and blood stasis syndrome. 2. Liver and kidney deficiency diabetes mellitus peripheral neuropathy longer course and older. 3. Phlegm and blood stasis collateral type patients BMI was significantly higher than other groups. 4. There were different degrees of blood glucose and blood lipid abnormalities between different syndrome groups.
【学位授予单位】:辽宁中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R259;R277.7

【相似文献】

相关期刊论文 前10条

1 程立新;气虚血瘀证浅谈[J];现代中医药;2003年05期

2 陈瑾;气虚血瘀证与循环系统[J];中国中医基础医学杂志;2003年02期

3 罗尧岳;气虚血瘀证动物模型的研究述评[J];湖南中医学院学报;2004年05期

4 刘海玲;中医血疗治疗中风气虚血瘀证36例疗效观察及护理体会[J];生物磁学;2005年03期

5 刘洪;李荣亨;;气虚血瘀证的实验研究概况[J];中医杂志;2005年06期

6 张娅;陈慧;李灿东;吴红霞;林云钗;;冠脉介入术后气虚血瘀证对抗栓疗效的影响[J];辽宁中医杂志;2011年09期

7 杨艳玲;曹雪滨;解亚楠;王祥贺;何建成;张刚;胡元会;李俊峡;;缺血性心肌病心力衰竭气虚血瘀证患者特异性血清标志物研究[J];中医杂志;2014年07期

8 李明贵;参芪芎通脉散治疗冠心病气虚血瘀证32例[J];湖南中医药导报;2002年01期

9 扈新刚;张允岭;柳洪胜;娄金丽;郑宏;闫妍;黄启福;;气虚血瘀证大鼠表征观察与分析[J];北京中医药大学学报;2006年12期

10 赵慧辉;侯娜;王伟;黄秀兰;;冠心病气虚血瘀证的蛋白质组学特征研究[J];中国中西医结合杂志;2009年06期

相关会议论文 前10条

1 陈全福;张敏州;王磊;杨广;;急性冠脉综合征不同年龄组之间危险因素与气虚血瘀证积分的相关性分析[A];第十次中国中西医结合学会心血管病学术大会暨第五次江西省中西医结合学会心血管病学术大会论文汇编[C];2010年

2 袁肇凯;黄献平;莫莉;胡志希;孙贵香;陈清华;;冠心病气虚血瘀证实验指标的临床研究[A];第二次全国中西医结合诊断学术研讨会论文集[C];2008年

3 任建勋;林成仁;王敏;刘建勋;;双参通冠方对复合因素诱导大鼠气虚血瘀证模型的干预作用[A];中华中医药学会中药实验药理分会第八届学术会议论文摘要汇编[C];2009年

4 王键;胡建鹏;赵辉;李净;李玉梅;;多因素复合制作气虚血瘀证局灶性脑缺血动物模型的研究[A];首届中国中医药实验动物科技交流会论文汇编[C];2002年

5 任建勋;刘建勋;林成仁;苗阳;陈可远;;冠心病不稳定性心绞痛患者气滞血瘀和气虚血瘀证的生物学基础比较分析[A];北京中医药学会2012年学术年会论文汇编[C];2012年

6 汪维红;万晓凤;鄢毅;;中药制剂治疗冠心病气滞血瘀和气虚血瘀证的临床比较研究[A];第六次全国中西医结合血瘀证及活血化瘀研究学术大会论文汇编[C];2005年

7 李健;张敏州;王磊;林晓忠;张翔炜;李松;;益气活血法治疗冠脉介入术后气虚血瘀证的临床观察[A];第八次全国中西医结合心血管病学术会议论文集[C];2007年

8 梁静涛;刘福友;;气虚血瘀证MCAO大鼠子代的同种证候及疾病趋势诱导形成实验研究[A];中华医学会第十三次全国神经病学学术会议论文汇编[C];2010年

9 闵婕;毛兵;;“益气活血”法提高慢性阻塞性肺疾病稳定期(气虚血瘀证)临床疗效研究[A];第十三次全国临床药理学学术大会论文汇编[C];2012年

10 姚民强;高晟;周静;;联合应用芪参益气滴丸及西药对冠心病心绞痛气虚血瘀证患者内皮功能及心功能的影响[A];第十二次全国中西医结合微循环学术会议会议指南及论文摘要[C];2012年

相关重要报纸文章 前2条

1 张艳 方素清 姜凯 宋婷婷;慢心衰气虚血瘀证大鼠模型[N];中国中医药报;2006年

2 于涌;中医药在冠心病不同发展阶段的应用[N];中国医药报;2012年

相关博士学位论文 前7条

1 李健;冠状动脉介入术对冠心病气虚血瘀证影响的临床研究[D];广州中医药大学;2007年

2 刘涛;气虚血瘀证(心肌缺血)动物模型及蛋白质组学研究[D];北京中医药大学;2007年

3 仇琪;基于蛋白质组学技术的大鼠心肌缺血气虚血瘀证相关生物学标志分子研究[D];北京中医药大学;2010年

4 其其格;冠心病不稳定性心绞痛气虚血瘀证及炎症相关性研究[D];北京中医药大学;2010年

5 张娅;冠脉介入术后气虚血瘀证与CYP2C19*2基因多态性的相关性及脑心通胶囊干预作用的研究[D];福建中医药大学;2011年

6 莫莉;冠心病气虚血瘀证的临床特征及益气活血法干预的实验研究[D];湖南中医药大学;2008年

7 曹刚;脉络通瘀汤治疗脱疽气虚血瘀证对气体信号分子的影响及疗效观察[D];北京中医药大学;2014年

相关硕士学位论文 前10条

1 包娅琼;益气活血通络方对慢性肾脏病3期、4期气虚血瘀证患者的临床观察—血清PTX3、LP(a)、hs-CRP的影响[D];安徽中医药大学;2015年

2 陈城;脑络欣通颗粒治疗缺血性中风(脑梗死)急性期气虚血瘀证临床研究[D];安徽中医药大学;2015年

3 张楠;超声新技术观察二参通脉颗粒对心肌梗死气虚血瘀证疗效的研究[D];山东大学;2015年

4 张巧娜;冠心病气虚血瘀证与冠状动脉血管内皮细胞功能失调相关性研究[D];华北理工大学;2015年

5 封雪;黄芪正君汤治疗稳定性心绞痛(气虚血瘀证)的临床疗效观察[D];长春中医药大学;2015年

6 刘洋;参蛭通脉软胶囊治疗冠心病稳定型心绞痛(气虚血瘀证)的临床研究[D];辽宁中医药大学;2015年

7 王顺英;力克敏鼻喷剂对鼻鼽(气虚血瘀证)疗效观察及uLTD4的影响[D];成都中医药大学;2015年

8 张先元;基于“络病”理论运用补阳还五汤治疗慢性肺源性心脏病(气虚血瘀证)的临床研究[D];成都中医药大学;2015年

9 田康;缺血性中风病气虚血瘀证患者的脉图分析[D];山东中医药大学;2015年

10 赵慧鹃;中风参芪通络颗粒剂治疗缺血性中风后(恢复期)疲劳(气虚血瘀证)的临床观察[D];河南中医学院;2015年



本文编号:2217146

资料下载
论文发表

本文链接:https://www.wllwen.com/zhongyixuelunwen/2217146.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户14d16***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com